Free Trial

Ardent Health Partners (ARDT) Competitors

Ardent Health Partners logo
$12.57 -0.16 (-1.23%)
Closing price 03:59 PM Eastern
Extended Trading
$12.87 +0.30 (+2.39%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARDT vs. HIMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, CON, and SGRY

Should you be buying Ardent Health Partners stock or one of its competitors? The main competitors of Ardent Health Partners include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry.

Ardent Health Partners vs.

Hims & Hers Health (NYSE:HIMS) and Ardent Health Partners (NYSE:ARDT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.

Hims & Hers Health has a net margin of 8.19% compared to Ardent Health Partners' net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat Ardent Health Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
Ardent Health Partners N/A N/A N/A

Hims & Hers Health received 20 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 88.46% of users gave Ardent Health Partners an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
43
35.25%
Underperform Votes
79
64.75%
Ardent Health PartnersOutperform Votes
23
88.46%
Underperform Votes
3
11.54%

Hims & Hers Health currently has a consensus price target of $36.92, indicating a potential upside of 5.29%. Ardent Health Partners has a consensus price target of $20.58, indicating a potential upside of 63.67%. Given Ardent Health Partners' stronger consensus rating and higher possible upside, analysts plainly believe Ardent Health Partners is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
Ardent Health Partners
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
3.00

Ardent Health Partners has higher revenue and earnings than Hims & Hers Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B5.28-$23.55M$0.5464.93
Ardent Health Partners$5.97B0.30$53.90MN/AN/A

In the previous week, Hims & Hers Health had 41 more articles in the media than Ardent Health Partners. MarketBeat recorded 48 mentions for Hims & Hers Health and 7 mentions for Ardent Health Partners. Ardent Health Partners' average media sentiment score of 1.10 beat Hims & Hers Health's score of 0.64 indicating that Ardent Health Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
20 Very Positive mention(s)
6 Positive mention(s)
12 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Ardent Health Partners
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 1.7% of Ardent Health Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Hims & Hers Health and Ardent Health Partners tied by winning 8 of the 16 factors compared between the two stocks.

Get Ardent Health Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARDT vs. The Competition

MetricArdent Health PartnersGeneral medical & surgical hospitals IndustryMedical SectorNYSE Exchange
Market Cap$1.80B$12.88B$5.53B$19.02B
Dividend YieldN/A0.66%5.11%4.03%
P/E RatioN/A5.6022.6533.12
Price / Sales0.300.58401.9828.04
Price / CashN/A6.8638.1817.52
Price / BookN/A32.266.754.51
Net Income$53.90M$1.20B$3.22B$1.02B
7 Day Performance0.12%3.97%1.66%1.38%
1 Month Performance-2.67%0.34%4.17%-1.99%
1 Year PerformanceN/A10.88%16.17%5.28%

Ardent Health Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARDT
Ardent Health Partners
2.7484 of 5 stars
$12.57
-1.2%
$20.58
+63.7%
N/A$1.79B$5.97B0.0024,200Upcoming Earnings
Analyst Revision
Positive News
HIMS
Hims & Hers Health
2.3685 of 5 stars
$28.51
+1.5%
$38.08
+33.6%
+164.1%$6.33B$1.48B64.80650Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
High Trading Volume
GH
Guardant Health
3.9509 of 5 stars
$47.99
-0.6%
$49.00
+2.1%
+162.4%$5.92B$739.02M-13.481,790Analyst Forecast
News Coverage
Gap Up
OPCH
Option Care Health
3.8012 of 5 stars
$32.97
+0.2%
$33.75
+2.4%
+8.1%$5.42B$5.00B27.715,600Earnings Report
Analyst Upgrade
News Coverage
Positive News
RDNT
RadNet
4.0206 of 5 stars
$51.03
+1.5%
$69.75
+36.7%
+8.0%$3.78B$1.83B-728.908,970Positive News
SHC
Sotera Health
2.3986 of 5 stars
$11.26
+1.0%
$15.20
+35.0%
+2.7%$3.20B$1.10B45.043,000News Coverage
Gap Up
WGS
GeneDx
3.7608 of 5 stars
$112.49
+1.3%
$72.33
-35.7%
+291.6%$3.16B$305.45M-57.391,200Earnings Report
Analyst Forecast
News Coverage
Positive News
Gap Up
BTSG
BrightSpring Health Services
2.5539 of 5 stars
$17.31
+2.3%
$21.67
+25.2%
+64.0%$3.03B$11.27B-66.5835,000Upcoming Earnings
News Coverage
Positive News
PRVA
Privia Health Group
4.1127 of 5 stars
$23.20
+0.1%
$27.14
+17.0%
+27.6%$2.81B$1.74B232.02810Upcoming Earnings
Analyst Forecast
Short Interest ↓
News Coverage
Positive News
CON
Concentra Group Holdings Parent
N/A$21.64
+1.8%
$28.50
+31.7%
N/A$2.76B$1.90B14.3311,000Upcoming Earnings
Positive News
SGRY
Surgery Partners
3.2161 of 5 stars
$21.56
+0.4%
$34.75
+61.2%
-12.0%$2.75B$3.11B-44.9212,200Upcoming Earnings
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:ARDT) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners